Fiduciary Trust Co Purchases 6,395 Shares of Leidos Holdings, Inc. (NYSE:LDOS)

Fiduciary Trust Co grew its holdings in Leidos Holdings, Inc. (NYSE:LDOS) by 36.4% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 23,941 shares of the aerospace company’s stock after buying an additional 6,395 shares during the quarter. Fiduciary Trust Co’s holdings in Leidos were worth $3,902,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in LDOS. Atria Investments Inc boosted its stake in Leidos by 100.1% in the 3rd quarter. Atria Investments Inc now owns 8,837 shares of the aerospace company’s stock valued at $1,440,000 after buying an additional 4,421 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in Leidos by 51.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock valued at $136,491,000 after buying an additional 283,558 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in Leidos by 21.4% during the third quarter. Los Angeles Capital Management LLC now owns 55,165 shares of the aerospace company’s stock worth $8,992,000 after buying an additional 9,710 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. increased its holdings in shares of Leidos by 188.2% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 8,274 shares of the aerospace company’s stock worth $1,207,000 after buying an additional 5,403 shares in the last quarter. Finally, AQR Capital Management LLC boosted its holdings in shares of Leidos by 76.9% in the 2nd quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock worth $101,942,000 after acquiring an additional 303,775 shares in the last quarter. 76.12% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. TD Cowen lifted their price objective on Leidos from $175.00 to $200.00 and gave the company a “buy” rating in a research report on Wednesday, October 30th. Wells Fargo & Company reduced their price target on shares of Leidos from $230.00 to $205.00 and set an “overweight” rating on the stock in a research report on Tuesday. Barclays raised their price objective on shares of Leidos from $165.00 to $210.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. upped their target price on shares of Leidos from $175.00 to $185.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Truist Financial lowered their price target on shares of Leidos from $205.00 to $185.00 and set a “buy” rating for the company in a report on Friday, November 22nd. Two research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $187.77.

Insider Activity

In other Leidos news, Director Surya N. Mohapatra sold 2,748 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $194.97, for a total value of $535,777.56. Following the completion of the transaction, the director now directly owns 20,001 shares in the company, valued at $3,899,594.97. This trade represents a 12.08 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the business’s stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $184.94, for a total value of $193,632.18. Following the transaction, the director now directly owns 6,408 shares in the company, valued at $1,185,095.52. This trade represents a 14.04 % decrease in their position. The disclosure for this sale can be found here. 0.96% of the stock is owned by corporate insiders.

Leidos Stock Down 1.3 %

Leidos stock opened at $163.97 on Friday. The company has a 50 day moving average of $171.13 and a 200-day moving average of $156.67. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87. Leidos Holdings, Inc. has a twelve month low of $105.52 and a twelve month high of $202.90. The stock has a market capitalization of $21.88 billion, a PE ratio of 18.68, a price-to-earnings-growth ratio of 1.10 and a beta of 0.68.

Leidos (NYSE:LDOS) last released its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.96 by $0.97. The firm had revenue of $4.19 billion during the quarter, compared to analysts’ expectations of $4.06 billion. Leidos had a return on equity of 30.31% and a net margin of 7.37%. The company’s revenue was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.03 EPS. On average, equities research analysts anticipate that Leidos Holdings, Inc. will post 10.04 EPS for the current fiscal year.

Leidos Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Monday, December 16th will be given a dividend of $0.40 per share. The ex-dividend date is Monday, December 16th. This represents a $1.60 dividend on an annualized basis and a yield of 0.98%. This is an increase from Leidos’s previous quarterly dividend of $0.38. Leidos’s dividend payout ratio is 17.31%.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.